Ohio State Navbar

Sign In


​This program will focus on signal transduction pathways, drug-receptor interactions, in vivo drug studies in experimental animals (in particular transgenic animals),  the use of functional genomics to understand mechanisms of drug action and to discover novel drugs, and lastly, clinical research involving therapy of mental disorders.  The Division of Neuropsychopharmacology (a possible joint venture between Pharmacology, Psychiatry, and other Departments) would provide an administrative structure to foster this enormously important area.  Furthermore, it would encompass the CNS Focus Group of the PiPGx.  Importantly, it should integrate with a push for an Institute in the Neurobiology of Mental Disease, a possible emerging theme at OSU.